⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IMUX News
Immunic, Inc. Common Stock
Form 8-K
sec.gov
IMUX
Immunic, Inc. Announces 1-for-10 Reverse Stock Split
prnewswire.com
IMUX
Form 8-K
sec.gov
IMUX
Multiple Sclerosis Market Competitive Landscape Report 2026: Comprehensive Insights on Over 60 Companies and 75 Drugs by Product Type, Development Stage, Administration Route, and Molecule Type
globenewswire.com
SNY
IMUX
TLSA
BIIB
BMY
TGTX
Form 8-K
sec.gov
IMUX
Immunic to Participate in Scientific and Medical Conferences in April
prnewswire.com
IMUX
Form 8-K
sec.gov
IMUX
Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement
prnewswire.com
IMUX
Form 8-K
sec.gov
IMUX
Immunic Strengthens Its Board of Directors with the Appointment of Seasoned Biopharmaceutical Executive Jon Congleton
prnewswire.com
IMUX